Literature DB >> 852108

Sequential-saturation-type assay for serum 25-hydroxyvitamin D.

G Ellis, K Dixon.   

Abstract

We describe a method for measuring 25-hydroxyvitamin D in serum. The serum is denatured with ethanol, and the extract purified by chromatography on silicic acid to prevent potential interference from vitamin D and by other substances. 25-Hydoxyvitamin D is assayed by sequential saturation analysis in Tris-HCI buffer, pH 8.6, containing the surfactant Triton X-405 (2 ml/liter) to solubilize the steroid. Diluter, unpurifed normal human serum is used as the binder. The method is sensitive and precise. The dose-response curve is linear. The assay normally gives high count rates (12 000 to 20 000 cpm for the zero standard) and consequently 25-hydroxyvitamin D of low specific activity can be used if necessary. Serum 25-hydroxyvitamin D was determined in normal and osteomalacic subjects.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 852108

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  7 in total

1.  Serum markers of bone formation in parenteral nutrition patients.

Authors:  E W Lipkin; S M Ott; G L Klein; L J Deftos
Journal:  Calcif Tissue Int       Date:  1990-08       Impact factor: 4.333

2.  Racial and seasonal differences in 25-hydroxyvitamin D detected in maternal sera frozen for over 40 years.

Authors:  Lisa M Bodnar; Janet M Catov; Katherine L Wisner; Mark A Klebanoff
Journal:  Br J Nutr       Date:  2008-04-23       Impact factor: 3.718

3.  The 25-hydroxyvitamin D3 C-3 epimer: distribution, correlates, and reclassification of 25-hydroxyvitamin D status in the population-based Atherosclerosis Risk in Communities Study (ARIC).

Authors:  Pamela L Lutsey; John H Eckfeldt; Ejovwoke R Ogagarue; Aaron R Folsom; Erin D Michos; Myron Gross
Journal:  Clin Chim Acta       Date:  2015-01-09       Impact factor: 3.786

4.  Free 1,25-dihydroxyvitamin D levels in serum from normal subjects, pregnant subjects, and subjects with liver disease.

Authors:  D D Bikle; E Gee; B Halloran; J G Haddad
Journal:  J Clin Invest       Date:  1984-12       Impact factor: 14.808

5.  Measurement of Vitamin D for Epidemiologic and Clinical Research: Shining Light on a Complex Decision.

Authors:  Anne Marie Z Jukic; Andrew N Hoofnagle; Pamela L Lutsey
Journal:  Am J Epidemiol       Date:  2018-04-01       Impact factor: 4.897

6.  Racial variation in vitamin D cord blood concentration in white and black male neonates.

Authors:  Monika Eichholzer; Elizabeth A Platz; Jessica L Bienstock; Deborah Monsegue; Folasade Akereyeni; Bruce W Hollis; Ronald Horst; Nader Rifai; Michael N Pollak; Aline Barbir; Tanya Agurs-Collins; Sabine Rohrmann
Journal:  Cancer Causes Control       Date:  2012-11-09       Impact factor: 2.506

7.  Vitamin D deficiency in Europe: pandemic?

Authors:  Kevin D Cashman; Kirsten G Dowling; Zuzana Škrabáková; Marcela Gonzalez-Gross; Jara Valtueña; Stefaan De Henauw; Luis Moreno; Camilla T Damsgaard; Kim F Michaelsen; Christian Mølgaard; Rolf Jorde; Guri Grimnes; George Moschonis; Christina Mavrogianni; Yannis Manios; Michael Thamm; Gert Bm Mensink; Martina Rabenberg; Markus A Busch; Lorna Cox; Sarah Meadows; Gail Goldberg; Ann Prentice; Jacqueline M Dekker; Giel Nijpels; Stefan Pilz; Karin M Swart; Natasja M van Schoor; Paul Lips; Gudny Eiriksdottir; Vilmundur Gudnason; Mary Frances Cotch; Seppo Koskinen; Christel Lamberg-Allardt; Ramon A Durazo-Arvizu; Christopher T Sempos; Mairead Kiely
Journal:  Am J Clin Nutr       Date:  2016-02-10       Impact factor: 7.045

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.